Showing results (661-670 of 2,814) with videos related to
Sort By:
Pageof 282
Diabetes Technology & Therapeutics|February 5, 2024
Driving-Related Glucose Patterns Among Older Adults with Type 1 DiabetesHye Jin Kwon, Steven Trawley, Sara Vogrin, et al.Diabetes Technology & Therapeutics|February 5, 2024
Impact of Flash Glucose Monitoring on the Fear of Hypoglycemia Phenomenon in Adults with Type 1 DiabetesPablo Rodríguez de Vera Gómez, Carmen Mateo Rodríguez, Beatriz Rodríguez Jiménez, et al.Diabetes Technology & Therapeutics|May 17, 2024
Expert Panel Recommendations for a Standardized Ambulatory Glucose Profile Report for Connected Insulin PensGregg D Simonson, Amy B Criego, Tadej Battelino, et al.Diabetes Technology & Therapeutics|April 25, 2024
Validation of the UVA Simulation Replay Methodology Using Clinical Data: Reproducing a Randomized Clinical TrialMaría F Villa-Tamayo, Patricio Colmegna, Marc BretonDiabetes Technology & Therapeutics|April 26, 2024
Point-Counterpoint: The Need for Do-It-Yourself (DIY) Open Source (OS) AID Systems in Type 1 Diabetes ManagementGregory P Forlenza, Ideen Tabatabai, Dana M LewisDiabetes Technology & Therapeutics|November 13, 2023
Diabetic Ketoacidosis at Diagnosis in Youth with Type 1 Diabetes Is Associated with a Higher Hemoglobin A1c Even with Intensive Insulin ManagementDessi P Zaharieva, Victoria Y Ding, Ananta Addala, et al.Diabetes Technology & Therapeutics|October 18, 2023
Two Years with a Tubeless Automated Insulin Delivery System: A Single-Arm Multicenter Trial in Children, Adolescents, and Adults with Type 1 DiabetesAmy B Criego, Anders L Carlson, Sue A Brown, et al.Diabetes Technology & Therapeutics|October 2, 2023
Real-World Use of Control-IQ Technology Is Associated with a Lower Rate of Severe Hypoglycemia and Diabetic Ketoacidosis Than Historical Data: Results of the Control-IQ Observational (CLIO) Prospective StudyRishi Graham, Lars Mueller, Michelle Manning, et al.Diabetes Technology & Therapeutics|October 2, 2023
Effects of 12-Week Freestyle Libre 2.0 in Children with Type 1 Diabetes and Elevated HbA1c: A Multicenter Randomized Controlled TrialCraig A Jefferies, Alisa Boucsein, Sara E Styles, et al.Diabetes Technology & Therapeutics|September 26, 2023
Therapy Settings Associated with Optimal Outcomes for t:slim X2 with Control-IQ Technology in Real-World Clinical CareLaurel H Messer, Marc D BretonPageof 282